News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
Presentation TCT 2023 The Conundrum of Clinical Trials in Cardiogenic Shock Presenter: Navin Kapur October 25, 2023
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2021 GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF Michael O'Riordan November 06, 2021
Presentation TCT 2021 GUIDE-HF: A Randomized Trial of Hemodynamic-Guided Management of Heart Failure – Outcomes According to Ejection Fraction Presenter: Michael Zile November 06, 2021
News Conference News TCT 2020 MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI Michael O'Riordan October 17, 2020
News Conference News TCT 2020 MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant? Shelley Wood October 16, 2020
News Opinion Editor's Corner TCT 2020 TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More Shelley Wood October 09, 2020
News Conference News TCT 2019 COAPT at 3 Years: Crossover Patients See Benefits From MitraClip Shelley Wood September 28, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL Shelley Wood September 28, 2019
Presentation TCT 2019 Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations Presenter: Anthony Gershlick September 27, 2019
Presentation TCT 2019 Industry Perspectives on Controlled Trials for Shock Devices Presenter: Seth Bilazarian September 27, 2019
Presentation TCT 2019 Industry View on Controlled Trials for Heart Failure and Shock Devices Presenter: William Abraham September 27, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News TCT 2018 REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR Yael L. Maxwell September 23, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018